Kalvista Pharmaceuticals Contact Us
KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the Eur…
WebKalVista Pharmaceuticals, Inc. has locations in the US and in the UK. Click to learn more! Contact Us. Locations KalVista Pharmaceuticals, Inc. United States. Email Addresses. info@kalvista.com. medinfo@kalvista.com. Phone +1 (857) 999 0075 Fax …
See Also: Phone Number Preview / Show details
KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc
WebJun 2, 2023 · KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI) Jun 2, 2023. All News. Footer. About KalVista; Products & …
See Also: Databases Preview / Show details
KalVista Pharmaceuticals, Inc. LinkedIn
WebKalVista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors. Website …
See Also: Phone Number Preview / Show details
KalVista Pharmaceuticals to Present HAE Attack Journey …
WebJul 14, 2023 · KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and …
See Also: Phone Number Preview / Show details
KalVista Pharmaceuticals Announces $58 Million Registered Direct
WebDec 27, 2022 · KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and …
See Also: Phone Number Preview / Show details
KalVista Pharmaceuticals to Present HAE Attack Journey Data at …
Web1 day ago · KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and …
See Also: Databases Preview / Show details
KalVista Pharmaceuticals to Present at Jefferies Global …
WebMay 31, 2023 · KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and …
See Also: Phone Number Preview / Show details
KalVista Pharmaceuticals Presents New Data at 2023 Meeting of …
WebJun 12, 2023 · KalVista Pharmaceuticals, Inc. Jarrod Aldom Vice President, Corporate Communications (201) 705-0254 jarrod.aldom@kalvista.com. Ryan Baker Head, …
See Also: Databases Preview / Show details
Anabela Quelha Email & Phone Number Kalvista.
WebMar 18, 2023 · Anabela Quelha is a Director, Business Operations (US) at Kalvista Pharmaceuticals based in Cambridge, Massachusetts. Previously, Anabela was a Di …
See Also: Phone Number Preview / Show details
Stock Market Franklin Credit Management Corporation
Web1 day ago · KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and …
See Also: Credit Union Services Preview / Show details
KalVista Pharmaceuticals Crunchbase Company Profile & Funding
Web51-100 Post-IPO Equity Public www.kalvista.com 7,635 Highlights Stock Symbol NASDAQ:KALV Acquisitions 1 Total Funding Amount $297.7M Contacts 43 Employee …
See Also: Contact Support Preview / Show details
Investors Overview KalVista Pharmaceuticals, Inc.
WebKalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases …
See Also: Atm Preview / Show details
Kalvista Pharmaceuticals Inc (KALVQ) Quote Press Release
WebDec 5, 2022 · KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease …
See Also: Phone Number Preview / Show details
KALV KalVista Pharmaceuticals, Inc. Yahoo Finance
WebCAMBRIDGE, Mass. & SALISBURY, England, July 07, 2023--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the …
See Also: Finance Preview / Show details
KalVista Pharmaceuticals Announces Termination of KVD824 …
WebOct 4, 2022 · CAMBRIDGE, Mass. & SALISBURY, England, October 04, 2022--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company …
See Also: Phone Number Preview / Show details
KalVista Pharmaceuticals Announces $58 Million Registered Direct …
WebDec 27, 2022 · The Company intends to use the proceeds of this $58 million offering to fund clinical trials, commercial sales development, research, working capital, capital …
See Also: Phone Number Preview / Show details
KalVista Pharmaceuticals to Present at Upcoming Investor …
WebNov 7, 2022 · KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease …
See Also: Phone Number Preview / Show details